chrisvoncsefalvay/vaers-outcomes huggingface dataset:
LEFT ARM STARTED LOSING FEELING AND STRENGTH/LOST AROUND EIGHTY PERCENTAGE OF STRENGTH IN FINGERS; LEFT WRIST FOREARM FEELS NUMB  ALONG WITH REAR DELTOID MIDDLE DELTOID/RIGHT PINKY FEELING A BIT NUMB; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 09-OCT-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On OCT-2021, Laboratory data included: MRI (NR: not provided) Negative, Negative. On 14-OCT-2021, the patient experienced left arm started losing feeling and strength/lost around eighty percentage of strength in fingers. On 14-OCT-2021, the patient experienced left wrist forearm feels numb along with rear deltoid middle deltoid/right pinky feeling a bit numb. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from left wrist forearm feels numb along with rear deltoid middle deltoid/right pinky feeling a bit numb, and left arm started losing feeling and strength/lost around eighty percentage of strength in fingers. This report was non-serious.
sharp pain in left jaw when touched; This is a spontaneous report from a contactable consumer(patient).   A 53-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: en5318) via an unspecified route of administration in left arm on 01Feb2021 at 09:30 (at the age of 53-years-old) as 1st dose, single dose for covid-19 immunisation. Facility type vaccine was clinic. Medical history included thyroid, high blood pressure and arthritis. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. No known allergies reported. The patient's concomitant medications were not reported. Other medications in two weeks reported. The patient did not receive any vaccines within four weeks prior to the vaccination. On 02Feb2021 at 08:00, the patient experienced, sharp pain in left jaw when touched. The patient did not receive any treatment for the event. Outcome of the event was not recovered.   Follow-up attempts are completed. No further information is expected.
Narrative:  58y.o. MALE with a h/o HCC, alcoholic cirrhosis, depression, h/o PE, HTN, HLD, BPH, GERD and hyperglycemia who presented to the ED (on 9/2/21) for altered mental status. Of note, the patient was admitted last month for acute hepatic encephalopathy. The patient tested positive in the emergency room for covid today. Pt had received vaccines from a NON-AGENCY source documented in chart as given on 1/29/2021 & 2/19/2021. Pt with positive covid pneumonia admitted for Hepatic Encephalopathy exacerbated by covid positive pneumonia infection. Pt treated and discharged on 9/8/21.
progressive numbness & swelling starting in feet progressing to neck, SOB, joint pain lasted 3-4 wk total;seen @ hosp;
about a week after my shot, I started having heart palpitations and fainting spells. It feels like my heart is substantially weaker and its not improving.
Patient received varicella vaccine in lower left deltoid on 13 Dec 07, at which time influenza vaccine was given in left upper deltoid.  This was her second varicella vaccine, the first was given on 9 Dec 99.  Earlier that day she had been seen by her primary pediatrician for rhinorrhea and fever of 100, she was diagnosed with allergic rhinitis.  Her pediatrician directed her to the immunization clinic to get influenza and varicella shot since she has asthma.  The following day about 24 hours after vaccination she was noted to have a blister rash on her arm at the site of the varicella vaccine.  She was seen at a satellite pediatric clinic where she was prescribed (per Mom) oral antibiotic and topical antibiotic.  The following day the blistering rash was larger and then it popped.  Mom states the erythema extended from her elbow to shoulder, and her fingers were swollen.  The following day she returned to the satellite peds clinic and they recommended an infectious disease referral.  Today (4 days after vaccination) she has a shallow ulceration with minimal erythema just at vaccination site.  Mom reports that the antibioitic ointment causes itching when they put it on so we will investigate possible neomycin sensitivity.
Vaccine kept in refrigerator on 04Nov2021, expiration date is 13Oct2021, administered on 02Dec2021; doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine kept in refrigerator on 04Nov2021, expiration date is 13Oct2021, administered on 02Dec2021) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine kept in refrigerator on 04Nov2021, expiration date is 13Oct2021, administered on 02Dec2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine kept in refrigerator on 04Nov2021, expiration date is 13Oct2021, administered on 02Dec2021) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  HCP said that there was a confusion between the expiration date printed in the carton and the expiration date when the quick response (QR) code scanned. On 04 NOV 2021, vial was initially stored in the refrigerator. No temperature excursions was noted and patient did not experience any adverse event.  Treatment medications were not reported.
High fever of 105. Spent most of night in bath tub. Fever lasted 3 days. No antibiotic Tylenol/Advil only
Fever of 101.1+ lasting 10 hours, on-and-off low-grade fever for 48 hours Headache, including eye and jaw pain, lasting 3+ days Dizziness; inability to stand or walk due to head pain and fear of fainting (dizziness lasted ~24 hours) Nausea and loss of appetite (ongoing) Body aches, including spinal pain and hip pain lasting 48 hours
Have been getting styes to both eyes regularly since receiving my second dose. I never got a stye before in my life.
The day after dose 2 I woke up with lymph node pain in my face and chin and my underarms and breast tissue. I noticed severe swelling in my left breast tissue and my under arms were very sore and tender. I reached out to doctor and advised to monitor. I woke up Wednesday (4 days after dose 2) the swelling had dissipated and pain was gone. I used ibuprofen for the pain.
Patient states that after patient received COVID shot on Monday, 09/27/2021, around 8:30am that later on in the day around 2:30 pm the patient started to break out. As of Wednesday, 09/29/2021 around 12:45 pm, when patient came to pharmacy that she had been itching since ~2:30pm on Monday and was still itching and had been broken out in welps since Monday afternoon.
9hrs after-site soreness, fever 100.9, body aches 24hrs after- site sorness, fever 101, body aches, extreme fatigue 48hrs after- temp 99.8, fatigue, extreme headache, nausea, extremely lightheaded and dizzy 72hrs and 96hrs after- temp fluctuation 99-101, mild fatigue, mild headache, extremely lightheaded and dizzy
No adverse events reported. Mom states baby has had some shivering episodes like when somebody gets cold, about 4 episodes in the last few days , mom states baby has normal activity and, she has not had any fevers after the vaccine.
On 6/25/01, pt had generalized tonic/clonic seizure with temperature of 102F. No other source of temperature other than recent vaccine.
fluid devel on rt knee; p/x-ray-MRI, blood work & bone scan dx was Juvenile Rheumatoid Arthritis;
had an excursion and were administered to a patient with no reported adverse event; had an excursion and were administered to a patient with no reported adverse event; Initial information received on 08-Sep-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 3 years old male patient who  were administered vaccine post excursion with no reported adverse event , after receiving vaccine TYPHOID VI POLYSACCHARIDE VACCINE [TYPHIM VI].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 07-Sep-2022, the patient received a  dose of suspect TYPHOID VI POLYSACCHARIDE VACCINE (lot U2A471M  and expiration date: 02-Nov-2023) at a dose of 0.5ml total dose via intramuscular route in the left arm for vaccination.  On 07-Sep-2022, the patient developed a non-serious had an excursion and were administered to a patient with no reported adverse event (poor quality product administered)(latency: same day) (product storage error).  Action taken :not applicable.  It was not reported if the patient received a corrective treatment for the events.   Outcome: unknown for both events   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weakness and heaviness in her right hand; 30 minutes later it went up her right arm and down her right leg.  She couldn't walk and needed to be escorted by her step-father to the car.
There was a white, raised mark at the injection site surrounded by a large purplish-red hot area on the affected arm. The patient was diagnosed with early cellulitis. She was given a Kenalog injection by her doctor and was given a prescription for Doxycycline 100mg #14 1 bid for 7 days.
A couple hours after getting the flu shot, the injection site was swollen and a little res. By the end of the day it was warm to the touch. The following days the swelling got worse and it was even warmer. She was exhausted and got a low grade fever.
SORE ARM; FATIGUE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. The batch number is not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced sore arm. On MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fatigue and sore arm was not reported. This report was non-serious.
p/vax pt  circular; reddened 4'' circumference; warm to touch; painful w/palpation;on 9/30 circular mass to touch; 5cm induration at inj site
Patient left facility with mother after about 2 hours returned with redness to back of left thigh. Thigh was a little warm to touch but not hot. Patient was not in any pain or distress. Dr. examined the area push on the leg no sign of pain in patient. Dr advise to put cold compress on sight and to com back for observation.
Post-vax the patient developed joint pain on 06/25/2001. The patient was seen in the ER and discharged home. On 06/27/2001 the patient was febrile, vomiting, had joint stiffness with pain, weakness and difficulty breathing. The patient is returning to the ER today.
Enlarged lymph nodes  for months after vax, extreme dizziness, blurred vision, lethargy all still occurring since first dose (received 1st dose end of July and second dose in August)
administration error and another booster shot was given; received booster dose instead of full dose; body aches; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body aches), EXTRA DOSE ADMINISTERED (administration error and another booster shot was given) and ACCIDENTAL UNDERDOSE (received booster dose instead of full dose) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On 17-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced MYALGIA (body aches). On 17-Dec-2021, the patient experienced ACCIDENTAL UNDERDOSE (received booster dose instead of full dose). On 18-Dec-2021, the patient experienced EXTRA DOSE ADMINISTERED (administration error and another booster shot was given). On 17-Dec-2021, ACCIDENTAL UNDERDOSE (received booster dose instead of full dose) had resolved. On 18-Dec-2021, EXTRA DOSE ADMINISTERED (administration error and another booster shot was given) had resolved. At the time of the report, MYALGIA (body aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: decreased (Low) low antibody primary immunodeficiency. On an unknown date, Blood immunoglobulin A: decreased (Low) low IGA level.         No concomitant medications reported by reporter No treatment medications provided by the reporter.  Patient was immunocompromised received booster dose instead of full dose on Friday 17-Dec-2021. Pharmacist made administration error and another booster shot was given on Saturday 18-Dec-2021 to equivalent full dose. Pharmacist claim he contacted Moderna to double check before giving second booster shot.   This case was linked to MOD-2021-417037 (Patient Link).
Appears that pt. has received 2 doses of Moderna vaccine and 1 dose of J & J vaccine.  The first dose given was Moderna, the second dose given was J & J.  Third dose given was Moderna.  Pt. presented card showing he had only received the first Moderna vaccine.  Attempted to contact pt. by phone on 10/15/21 without success.
Myalgia & Fever Narrative:  fever to 101F, chills, severe myalgia
Nurse administered undiluted dose of Pfizer for ages 5-11, dose #1 to patient. Guardian informed of error post vaccination via phone call. Guardian states all patients were feeling "fine" at time of phone call. Guardian advised to monitor injection sites for adverse reaction, and call clinic back if any adverse effects occur. Nurse addressed all questions and concerns. Dr. and supervisors aware.
Vaccine given 12/1 at 10:30 AM. Pt immediately reacted with increased temp and SOB. BENADRYL given 25mg stat and q 8 hours. Pt alert/oriented. 12/2 At 1:55 AM, pt temp 102.7, TYLENOL given. 12/3 Temp 99, pulse 110 at 1000 AM, oriented to self only. 12/4 At 0500 pt died. * Pt on hospice; dx: Parkinson's.  12/9/09 Death certificate received. DOD 12/4/2009. Cause of death: Respiratory Failure. Cardiac Failure. Parkinsons Disease.
Dizzy/weakness Pulse Rate: 83 SPO2: 100% Room air B/P:161/114 @10:30 AM.                          @10:34 B.P.:158/110 Increase Blood pressure and heart. Arrhythmia per cardiac monitor/EMT Given ASA  81 mg x4 =324 mg    Pt. was taken to the emergency room at 10:40 AM.
Four days after vaccination started to feel cramping pain from hip to down my legs. Had a Caesarean Section 2 years before and experienced the most pain in that area. Didn't see a doctor, just took Advil for the pain. Started feeling better 2 days later.
1 of 4 pts who exp an inject site react which included redness, hot to the touch, tenderness & swelling w/in 48 p/immun; all pts immunized from the same lot & recovered w/no residual sequelae; one of the four pts treated w/ATB;
Sore arm; Rash in the back that moves to the "bellybutton"; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and RASH (Rash in the back that moves to the "bellybutton") in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and RASH (Rash in the back that moves to the "bellybutton"). At the time of the report, PAIN IN EXTREMITY (Sore arm) and RASH (Rash in the back that moves to the "bellybutton") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications details were not reported by the reporter. Treatment medication was not reported by the reporter.
After having received my second Shingrix vaccine, I had a much more severe reaction than I did to the first shot. My arm was incredibly sore the first through sixth days with swelling, itching, fever, chills, and overall body aches. Day five the swelling decreased and day six is merely red, itchy, and hot, with only moderate pain in the arm.
The next day after I got my vaccine I had a very extreme headache and body aches which lasted for month, blood pressure was in influx extremely high then extremely low. Contracted Covid twice.
pt recvd vax 5MAR93 & did alright in clinic then 2 1/2-3 hrs later pt devel crying & holding leg; called mom @ home 600 that eve & pt had t103.7; would not bear wt on leg; leg swollen reddened & hot to touch; small knot lt leg;
Received IPV vaccine right thigh afternoon of 2/26/03. Mom noted large amount swelling entire R thigh that evening. Seen in office 2/27/03. Afebrile. 6x10cm irregular area redness, swelling entire thigh, not painful. Placed on Keflex 250mg bid x 7-10 days.
Became lightheaded and nauseous after receiving vaccine and walking to play room; sat in chair, still lightheaded, BP low, pulse weak and laid pt. down, gave juice and crackers BP at 210 - 62/40 and at 2:18 68/48 sitting, was pale when BP was low
My Sugar level have shot up very high. It is not going below 250 and goes to 390 after eating!; This is a spontaneous report from a contactable consumer (patient).  A 65-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered at the left arm on 17Feb2021 16:15 at single dose for COVID-19 immunization. Medical history included ongoing diabetes mellitus (diabetic). Concomitant medications were none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was vaccinated at a pharmacy or drugstore. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. On 17Feb2021, the patient's sugar level had shot up very high. It was not going below 250 and went to 390 after eating. No therapeutic measure was taken as a result of the event. Clinical outcome of the event was not recovered.  Information on the lot/batch number has been requested.
tested positive for Covid/4 people at a doctor's office (2 doctors and 2 office managers) tested positive on an rapid-antigen test after receiving the whole series; tested positive for Covid/4 people at a doctor's office (2 doctors and 2 office managers) tested positive on an rapid-antigen test after receiving the whole series; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported similar events for 4 patients, calling on behalf of another office. This report is for 3rd of 4 patient.   A patient of unspecified age and gender received the 1st and 2nd doses of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose on an unspecified date for Covid-19 immunisation.  The patient medical history and concomitant medications were not reported. The patient was tested positive for Covid after receiving the 2nd dose over 15 days before this report/4 people at a doctor's office (2 doctors and 2 office managers) tested positive on an rapid-antigen test 15 days after receiving the whole series on an unspecified date. The patient had no Covid symptoms, feeling fine after both doses. The patient underwent lab tests and procedures which included Sars-cov-2 test (rapid antigen test kit): positive. The outcome of events was unknown. Reporter was wondering if it was a false positive.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021076785 same reporter/drug/event, different patient
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare providers recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related injuries. In 2015, a pharmacist administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). In 2016, the patient was treated by a physician at a hospital for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Sx onset 7/15/21 with cough, chills & muscle aches. Visited son, his wife & newborn. Son and DIL are both + cases. Tested on 7/26/21 which resulted as positive.
Received the Covid-19 vaccine at about1515. She reports symptoms of L eye blurred at about 1525; called over nurse at 1540 and let her know.  Her neuro assessment is wnl except for the blurred vision.  1540 vital signs were B/P 124/80  pulse 72 and 98% pulse ox.  At 1545 b/p was 108/70, pulse 77, and pulse ox 98%.  Husband did notify us that his wife has alzheimer's. Recommended to be evaluated in ED; agreed.  First response called; team came at 1555; able to walk to wheelchair. Left accompanied by ED team and husband.